Validation of the eHealthResp online course for pharmacists and physicians: A Delphi method approach
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Framework: The inappropriate use of antibiotics for respiratory tract infections is dispersed worldwide, thus being a strong contributor to antibiotic resistances. As the use of educational interventions among health practitioners is shown to have an impact on judicious antibiotic use, an online course (eHealthResp) has been developed, especially targeted to pharmacists and physicians. Thus, the main goal of this study is to validate the contents of the online course eHealthResp.
Methods: This two-round Delphi study involved the recruitment of a multidisciplinary panel (n = 19), to which the questionnaires of the first round were sent. After the first round, a report summing up the results has been forwarded to the panel, along with a new, reformulated version of the questionnaire.
Results: After the two rounds of the Delphi process, consensus was evaluated. Six clinical cases and fifty-one treatments obtained minor consensus [60–75%] or full consensus (≥75%). The question on antibiotic practice has obtained a consensus >90% on both rounds.
Conclusions:
The validation of the contents based on experts’ consensus has been an essential approach to improve eHealthResp’s online course, as valuable feedback has been provided by the panel on both rounds
Description
Bibliographic citation
Biomedicine & Pharmacotherapy 2021, 40: 111739. https://doi.org/10.1016/j.biopha.2021.111739
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1016/j.biopha.2021.111739Sponsors
Project PTDC/SAU-SER/31678/2017 was supported by the operational program of competitiveness and internationalisation, in its FEDER/FNR component POCI-01-0145-FEDER-031678, the Foundation for Science and Technology, in its state budget component (OE), and the Institute of Biomedicine (iBiMED) (UIDB/04501/2020 and POCI-01-0145-FEDER-007628)
Rights
© 2021 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Atribución 4.0 Internacional
Atribución 4.0 Internacional








